12 November 2015 - News that Novartis's heart drug Entresto cuts the risk of re-hospitalisation might have helped Chief Executive Joe Jimenez realise his ambition of getting insurers to pay more for treatments when they cut overall medical costs.

For more details, go to: http://finance.yahoo.com/news/novartis-roche-outcome-based-drug-132851810.html